Literature DB >> 22580347

T cell populations in the pancreatic lymph node naturally and consistently expand and contract in NOD mice as disease progresses.

Idania Marrero1, Allen Vong, Yang Dai, Joanna D Davies.   

Abstract

Nonobese diabetic (NOD) mice develop spontaneous autoimmune Type 1 diabetes (T1D) that results from the destruction of insulin secreting β cells by diabetogenic T cells. The activation of autoreactive T cells occurs in the pancreatic lymph nodes (PLN) from where effector T cells migrate to the pancreas. This study was designed to explore whether T cell populations in the NOD PLN expand in a predictable and reproducible way during disease progression. Complementary determining region (CDR) 3 length spectratype analysis of 19 TCR Vβ families was used to identify the relative frequency of T populations in PLN of 4 and 10 week old NOD mice and mice at T1D onset. Significant and highly reproducible changes in specific T cell populations were detected in 14 of Vβ families tested at all stages of disease. However, of these, the CDR3 spectratype of only four Vβ families was significantly more perturbed at T1D onset than in 10 week old mice. Intriguingly, when diabetes was induced in 10 week old mice with cyclophosphamide (CYP) the same four Vβ families, Vβ5.1, Vβ9, Vβ10, and Vβ15, were again significantly more perturbed than in the untreated non-diabetic age matched mice. Taken together the data show that while T cell responses in PLN of NOD mice are heterogeneous, they are ordered and consistent throughout disease development. The finding that within this heterogeneous response four Vβ families are significantly more perturbed in diabetic mice, whether spontaneous or induced, strongly suggests their selection as part of the disease process.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580347      PMCID: PMC3774157          DOI: 10.1016/j.molimm.2012.04.004

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  54 in total

1.  High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells.

Authors:  Lisa Föhse; Janine Suffner; Karsten Suhre; Benjamin Wahl; Cornelia Lindner; Chun-Wei Lee; Susanne Schmitz; Jan D Haas; Stella Lamprecht; Christian Koenecke; André Bleich; Günter J Hämmerling; Bernard Malissen; Sebastian Suerbaum; Reinhold Förster; Immo Prinz
Journal:  Eur J Immunol       Date:  2011-10-18       Impact factor: 5.532

Review 2.  TCR diversity and Treg cells, sometimes more is more.

Authors:  James B Wing; Shimon Sakaguchi
Journal:  Eur J Immunol       Date:  2011-10-20       Impact factor: 5.532

Review 3.  The molecular basis for public T-cell responses?

Authors:  Vanessa Venturi; David A Price; Daniel C Douek; Miles P Davenport
Journal:  Nat Rev Immunol       Date:  2008-03       Impact factor: 53.106

Review 4.  Tracking phenotypically and functionally distinct T cell subsets via T cell repertoire diversity.

Authors:  Katherine Kedzierska; Nicole L La Gruta; John Stambas; Stephen J Turner; Peter C Doherty
Journal:  Mol Immunol       Date:  2007-08-24       Impact factor: 4.407

5.  Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells.

Authors:  Cristina Ferreira; Yogesh Singh; Anna L Furmanski; F Susan Wong; Oliver A Garden; Julian Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

6.  T cell receptor restriction of diabetogenic autoimmune NOD T cells.

Authors:  E Simone; D Daniel; N Schloot; P Gottlieb; S Babu; E Kawasaki; D Wegmann; G S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Sven Brode; Tim Raine; Paola Zaccone; Anne Cooke
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

8.  TCR repertoire dynamics in the pancreatic lymph nodes of non-obese diabetic (NOD) mice at the time of disease initiation.

Authors:  Jelena Petrovic Berglund; Jelena Petrovc Berglund; Encarnita Mariotti-Ferrandiz; Eleftheria Rosmaraki; Håkan Hall; Pierre-André Cazenave; Adrien Six; Petter Höglund
Journal:  Mol Immunol       Date:  2008-05-08       Impact factor: 4.407

9.  Clonal expansions and loss of receptor diversity in the naive CD8 T cell repertoire of aged mice.

Authors:  Mushtaq Ahmed; Kathleen G Lanzer; Eric J Yager; Pamela S Adams; Lawrence L Johnson; Marcia A Blackman
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

10.  T-cell promiscuity in autoimmune diabetes.

Authors:  Li Li; Bo Wang; Jeffrey A Frelinger; Roland Tisch
Journal:  Diabetes       Date:  2008-05-20       Impact factor: 9.461

View more
  5 in total

Review 1.  Autoimmune Responses to Exosomes and Candidate Antigens Contribute to Type 1 Diabetes in Non-Obese Diabetic Mice.

Authors:  Yang D Dai; Huiming Sheng; Peter Dias; M Jubayer Rahman; Roman Bashratyan; Danielle Regn; Kristi Marquardt
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

Review 2.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

3.  Longitudinal Frequencies of Blood Leukocyte Subpopulations Differ between NOD and NOR Mice but Do Not Predict Diabetes in NOD Mice.

Authors:  Tanja Telieps; Meike Köhler; Irina Treise; Katharina Foertsch; Thure Adler; Dirk H Busch; Martin Hrabě de Angelis; Admar Verschoor; Kerstin Adler; Ezio Bonifacio; Anette-Gabriele Ziegler
Journal:  J Diabetes Res       Date:  2016-02-04       Impact factor: 4.011

4.  High-throughput sequencing of islet-infiltrating memory CD4+ T cells reveals a similar pattern of TCR Vβ usage in prediabetic and diabetic NOD mice.

Authors:  Idania Marrero; David E Hamm; Joanna D Davies
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

Review 5.  Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases.

Authors:  Miranda D Chávez; Hubert M Tse
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.